ECSP088801A - Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia - Google Patents

Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia

Info

Publication number
ECSP088801A
ECSP088801A EC2008008801A ECSP088801A ECSP088801A EC SP088801 A ECSP088801 A EC SP088801A EC 2008008801 A EC2008008801 A EC 2008008801A EC SP088801 A ECSP088801 A EC SP088801A EC SP088801 A ECSP088801 A EC SP088801A
Authority
EC
Ecuador
Prior art keywords
complex
neuralgia
treatment
salt
ketorolaco
Prior art date
Application number
EC2008008801A
Other languages
English (en)
Inventor
Salgado Lopez Enrique Raul Garcia
Hernandez Gustavo Barranco
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2006/004020A external-priority patent/MXPA06004020A/es
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of ECSP088801A publication Critical patent/ECSP088801A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a las combinaciones farmacéuticas de sal de ketorolaco y complejo B; a métodos para la fabricación de dichas combinaciones; y particularmente, a las combinaciones sinérgicas de ketorolaco y complejo B útiles en el tratamiento de pacientes que sufren de dolor moderado a severo y neuralgias de diversa localización
EC2008008801A 2006-04-10 2008-10-08 Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia ECSP088801A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA/A/2006/004020A MXPA06004020A (es) 2006-04-10 Composicion farmaceutica que comprende un analgesico y vitaminas

Publications (1)

Publication Number Publication Date
ECSP088801A true ECSP088801A (es) 2009-01-30

Family

ID=38580737

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008801A ECSP088801A (es) 2006-04-10 2008-10-08 Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia

Country Status (16)

Country Link
US (1) US20090227534A1 (es)
EP (1) EP2008655B1 (es)
JP (1) JP5244089B2 (es)
AR (1) AR060394A1 (es)
BR (1) BRPI0709967A2 (es)
CA (1) CA2649194C (es)
CO (1) CO6331430A2 (es)
CR (1) CR10360A (es)
DO (1) DOP2007000055A (es)
EC (1) ECSP088801A (es)
ES (1) ES2428342T3 (es)
GT (1) GT200800208A (es)
HN (1) HN2008001531A (es)
PE (2) PE20080363A1 (es)
PL (1) PL2008655T3 (es)
WO (1) WO2007116287A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008003230A (es) * 2008-03-07 2009-09-07 Senosiain S A De C V Lab Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
PL2616064T3 (pl) 2010-10-21 2020-02-28 Rtu Pharmaceuticals Llc Gotowe do zastosowania formulacje ketorolaku
AU2013201465B2 (en) * 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI809304B (zh) 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823167A (en) * 1955-03-29 1958-02-11 Vitarine Co Inc Stable vitamin b12-containing solution
FR4492M (es) * 1965-07-07 1966-10-10
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
MXPA02010828A (es) 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.

Also Published As

Publication number Publication date
ES2428342T3 (es) 2013-11-07
HN2008001531A (es) 2011-07-12
EP2008655A1 (en) 2008-12-31
PL2008655T3 (pl) 2013-11-29
EP2008655B1 (en) 2013-06-26
CA2649194A1 (en) 2007-10-18
JP2009533413A (ja) 2009-09-17
WO2007116287A1 (es) 2007-10-18
PE20080363A1 (es) 2008-05-25
PE20120122A1 (es) 2012-03-09
CA2649194C (en) 2014-12-30
BRPI0709967A2 (pt) 2011-08-02
CO6331430A2 (es) 2011-10-20
CR10360A (es) 2009-02-20
DOP2007000055A (es) 2007-10-31
GT200800208A (es) 2010-03-18
AR060394A1 (es) 2008-06-11
US20090227534A1 (en) 2009-09-10
JP5244089B2 (ja) 2013-07-24

Similar Documents

Publication Publication Date Title
IL274602A (en) Pharmaceutical tablets containing eltrombopag olamine, methods for their preparation and use thereof in the preparation of medicaments for treating thrombocytopenia
ECSP17013617A (es) “combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y nsaid”
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
UY32989A (es) Coposiciones terapéuticas concentradas de fosfolípidos
ECSP088904A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
CL2008002308A1 (es) Compuestos heterociclos, moduladores de beta secretasa; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos utiles para reducir la produccion de beta amiloide; y kit que contiene a uno de los compuestos, utiles para tratar enfermedades neurodegenerativas, tal como alzheimer.
GT200600028A (es) Compuestos y composiciones como inhibidores de proteina kinasa
EP2395834A4 (en) Sodium nitrite-containing pharmaceutical compositions
CL2007003523A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
GT200900023A (es) Formas farmacéuticas de dosificación oral que contienen un analgésico opioide.
BR112015020466A8 (pt) inibidores de cdc7, seus usos, e composição farmacêutica
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
MX350046B (es) Tratamientos para trastornos gastrointestinales.
GT200600260A (es) Derivados de benzamida y usos relacionados con los mismos
GT200600280A (es) Composiciones y metodos para el tratamiento de sintomas relacionados con el ciclo
AR086422A1 (es) Metodo para el tratamiento de tumores solidos avanzados, volasertib
ECSP088801A (es) Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia
AR070392A1 (es) Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de eleboracion
SV2010003773A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
PE20130147A1 (es) Combinacion farmaceutica de teobromina y un agente antitusivo no opioide
HN2010001775A (es) Composicion farmaceutica oral que comprende la combinacion de una sal de keterolaco y vitaminas del complejo b
AR055939A1 (es) Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso
CL2009000264A1 (es) Uso de una combinacion farmaceutica que comprende una sal de bis-tiazolio o uno de sus precursores y artemisina o uno de sus derivados, para el tratamiento y/o prevencion de la malaria severa; uso de la composicion farmaceutica y del kit farmaceutico que la comprenden.
AR067351A1 (es) Combinacion de picotamida con nafronil